AnalyzeDirect

Contractor KB, Kenny LM, Stebbing J, Al-Nahhas A, Palmieri C, Sinnett D, Lewis JS, Hogben K, Osman S, Shousha S, Lowdell C, Coombes RC, Aboagye EO. [¹¹C]choline positron emission tomography in estrogen receptor-positive breast cancer. Clin Cancer Res. September 2009;15(17):5503-5510.

Full Text – Open Access

Publication Date
September 2009

How Analyze was Used
“Regions of interest were drawn manually around tumor and normal tissues (normal breast and normal lung) using the Analyze software.”

Keywords
Breast Neoplasms/metabolism/pathology/radionuclide imaging
Carbon Radioisotopes/diagnostic use/pharmacokinetics
Choline/diagnostic use/pharmacokinetics
Female
Humans
Ki-67 Antigen/metabolism
Positron-Emission Tomography (PET)/methods
Radiopharmaceuticals/diagnostic use/pharmacokinetics
Receptor, ErbB-2/metabolism
Receptors, Estrogen/metabolism
Receptors, Progesterone/metabolism

Author Affiliation(s)
Department of Oncology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK. (KBC, LML, JS, CP, CL, RCC, EOA)

Department of Nuclear Medicine, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK. (AAN)

Department of Breast Surgery, Imperial College Healthcare NHS Trust, Charing Cross Hospital, London, UK. (DS, JES, KH)

Department of Cellular Pathology, Imperial College Healthcare NHS Trust, Charing Cross Hospital, London, UK. (SS)

GE-Imanet, Hammersmith Hospital, London, UK. (SO)

ID# 1323

Tags: Breast Neoplasms/metabolism/pathology/radionuclide imaging, Carbon Radioisotopes/diagnostic use/pharmacokinetics, Choline/diagnostic use/pharmacokinetics, ErbB-2 Receptor/metabolism, Estrogen Receptors/metabolism, Female, Humans, Ki-67 Antigen/metabolism, Positron-Emission Tomography (PET)/methods, Progesterone Receptors/metabolism, Radiopharmaceuticals/diagnostic use/pharmacokinetics